Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.
about
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Preclinical evaluation of the ...... tic for alcohol use disorders.
@en
Preclinical evaluation of the ...... tic for alcohol use disorders.
@nl
type
label
Preclinical evaluation of the ...... tic for alcohol use disorders.
@en
Preclinical evaluation of the ...... tic for alcohol use disorders.
@nl
prefLabel
Preclinical evaluation of the ...... tic for alcohol use disorders.
@en
Preclinical evaluation of the ...... tic for alcohol use disorders.
@nl
P2093
P2860
P1476
Preclinical evaluation of the ...... tic for alcohol use disorders.
@en
P2093
R Barchiesi
P2860
P2888
P356
10.1038/S41386-018-0015-Y
P407
P577
2018-02-05T00:00:00Z
P6179
1100838583